Lv5
1450 积分 2024-04-07 加入
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
10天前
已完结
Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
11天前
已完结
The Influence of Exemestane on the Lipid Profile in Breast Cancer Patients: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
13天前
已完结
Ezetimibe: a novel option for lowering cholesterol
16天前
已完结
Ezetimibe: a novel option for lowering cholesterol
16天前
已关闭
Ezetimibe - an update
16天前
已完结
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis
18天前
已完结
What can real-world data teach us about treating patients with unresectable hepatocellular carcinoma?
18天前
已完结
Sequencing of systemic therapy in unresectable hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis of randomized clinical trials
18天前
已完结
Clinical pharmacokinetics and metabolism of irinotecan (CPT-11)
19天前
已关闭
皖公网安备34019202002308
